$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"

특허 상세정보

Medicament for the treatment of viral skin and tumour diseases

국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판) A61K-031/20    A61K-031/12    A61K-031/35    A61P-015/00   
미국특허분류(USC) 514/558; 514/675; 514/560; 514/546; 514/934; 514/947; 514/967; 514/969; 514/453; 514/732
출원번호 UP-0495889 (2002-11-18)
등록번호 US-7858662 (2011-02-24)
우선권정보 DE-101 56 794(2001-11-19)
국제출원번호 PCT/EP2002/012919 (2002-11-18)
§371/§102 date 20040924 (20040924)
국제공개번호 WO03/043628 (2003-05-30)
발명자 / 주소
출원인 / 주소
대리인 / 주소
    Elbing, Karen L.
인용정보 피인용 횟수 : 3  인용 특허 : 38
초록

The invention relates to a medicament containing a compound of general formula (1), where R1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkynyl group, preferably a C11-C15 alkyl, alkylene or alkynyl group, particularly a C11-C13 alkyl, alkylene or alkynyl group, most preferably a C13 alkyl group, R2=independently, a straight or branched C1-C8 alkyl, alkylene or alkynyl group, preferably a C1-C6 alkyl, alkylene or alkynyl group, in particular a C2-C4 alkyl, alkylene ...

대표
청구항

The invention claimed is: 1. A pharmaceutical which comprises, as the pharmaceutically active compound, isopropyl myristate and a mixture of catechols comprising 4-15% (w/w) of (−)-epicatechol, 2-20% (w/w) of (−)-epicatechol gallate, 3-15% (w/w) of (−)-epigallocatechol, 40-75% (w/w) of (−)-epigallocatechol gallate, 0.1-1% (w/w) of (+)-gallocatechol and 1-10% (w/w) of (−)-gallocatechol gallate, and wherein the pharmaceutical comprises at least 5-50% (w/w) of isopropyl myristate. 2. A pharmaceutical as claimed in claim...

이 특허에 인용된 특허 (38)

  1. Fernandez-Pol Jose A.. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method. USP2000106127393.
  2. Nashimoto Kazuo,JPX ; Tashiro Yoshikazu,JPX ; Kosaka Yoshiomi,JPX ; Hara Yukihiko,JPX. Antiviral filter air cleaner impregnated with tea extract. USP1998055747053.
  3. Hara Yukihiko,JPX ; Nakayama Mikio,JPX. Chewing gum and production of the same. USP2001066248346.
  4. Hara Yukihiko (Shizuoka JPX) Asai Hajime (Nagoya JPX) Kitamikado Tadashi (Inuyama JPX) Yamamoto Hajimu (Nagoya JPX) Okushio Kazuo (Shizuoka JPX) Nakamura Kozo (Tokyo JPX). Complex of tea-leaf extract and active aluminum hydroxide. USP1990044913909.
  5. Hayakawa Fumiko (Otsu JPX) Ando Takashi (Kusatsu JPX) Kimura Takahide (Otsu JPX) Hara Yukihiko (Fujieda JPX). Composition for strengthening acid resistancy of teeth. USP1995115470565.
  6. Cheng Shu Jun,CNX ; Wang De Chang,CNX ; Hara Yukihiko,JPX. Composition for treating Condyloma acuminata. USP1998085795911.
  7. Bobier-Rival Carinne (Cergy FRX) Fournier Odile (Rueil Malmaison FRX) Fructus Alain (Courbevoie FRX). Cosmetic or dermatological compositions. USP1997075652266.
  8. McCook John P. (Guilford CT) Meyers Alan J. (Trumbull CT) Dobkowski Brian J. (Milford CT) Burger Allan R. (Passaic NJ). Cosmetic sunscreen composition containing green tea and a sunscreen. USP1994045306486.
  9. Kabara Jon J. (2088 Riverwood Drive Okemos MI 48864). Fatty acids and derivatives of antimicrobial agents. USP1977014002775.
  10. Nashimoto Kazuo,JPX ; Tashiro Yoshikazu,JPX. Gargling cup, antiviral mask, antiviral filter, antifungal, antibacterial, and antiviral filter air cleaner and air-clea. USP1999035888527.
  11. D'Jang Arthur H. K.. Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis. USP1999065910308.
  12. Liao, Shutsung; Hiipakka, Richard. Method and compositions for regulation of 5-alpha reductase activity. USP2004026696484.
  13. Shimamura Tadakatsu (4-4 ; Nishihara-1-chome Shibuya-ku Tokyo JPX) Hara Yukihiko (Fujieda JPX). Method for inhibiting and treating infection caused by influenza virus. USP1992085137922.
  14. Bailey David T. ; Yuhasz Ralph L. ; Zheng BoLin. Method for isolation of caffeine-free catechins from green tea. USP2001046210679.
  15. Cheng Shu Jun,CNX ; Wang De Chang,CNX ; Hara Yukihiko,JPX. Method for treating hyperplasia. USP1999105968973.
  16. Yamane Tetsuo,JPX ; Tsuchida Takao,JPX ; Gotou Hisaya,JPX ; Takahashi Daizou,JPX ; Takeda Hidetsugu,JPX. Method of improving quality of eggs by feeding tea polyphenol. USP1998065766595.
  17. Cheng Shu Jun,JPX ; Wang De Chang,JPX ; Zhen Yong Su,JPX ; Nishino Hoyoku,JPX ; Hara Yukihiko,JPX. Method of increasing the effectiveness of anti-metabolites. USP1998095804567.
  18. Hara Yukihiko (Fujieda JPX) Honda Miwa (Fujieda JPX). Method of inhibiting the activity of a
  19. Shimamura Tadakatsu (4-4 Nishihara 1-chome ; Shibuya-ku ; Tokyo JPX) Hara Yukihiko (Fujieda JPX). Method of preventing mycoplasma infection. USP1992045104901.
  20. Hara Yukihiko (Fujieda JPX) Hattori Masao (Toyama JPX). Method of preventing the formation or aggrevation of dental plaque and method for reducing cariogenesis. USP1993045204089.
  21. Shimamura Tadakatsu (4-4 ; Nishihara 1-chome ; Shibuya-ku Tokyo JPX). Method of preventing the transmission of infection caused by methicillin-resistant Staphylococcus aureus . USP1994105358713.
  22. Shimamura Tadakatsu,JPX ; Hara Yukihiko,JPX. Method of strengthening antibacterial action of antibiotics. USP1998095807564.
  23. Liao, Shutsung; Hiipakka, Richard A.. Methods and compositions for regulation of 5-α-reductase activity. USP2003066576660.
  24. Cheng Shu Jun,CNX ; Wang De Chang,CNX ; Hara Yukihiko,JPX ; Lee Insu P.,KRX ; Ahn Woong Shick,KRX. Methods for treating hyperplasia. USP2001036197808.
  25. Ekman Bo M. (MalmSEX) Larsson Kare V. (Bjrred SEX) Lindahl Ake R. (Skurup SEX) Rothman Ulf S. E. (Skanr SEX). Micro-capsules. USP1990064931284.
  26. Meyer Petrus J. (Randburg ZAX). Nitrous oxide containing dermatological composition. USP1997055633284.
  27. Patel Dinesh C. (Murray UT) Chang Yunik (Lakewood NJ). Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols. USP1989094863970.
  28. Voet, Martin A.. Photodynamic therapy for pre-melanomas. USP2004046723750.
  29. Bombardelli Ezio,ITX ; Morazzoni Paolo,ITX ; Mustich Giuseppe,ITX. Polyphenol fractions of tea, the use thereof and formulations containing them. USP2000086096359.
  30. Okada Fumio (Makurazaki JPX). Process for producing catechins. USP1981024248789.
  31. Hara Yukihiko (Shizuoka JPX). Process for the production of a natural antioxidant obtained from tea leaves. USP1987064673530.
  32. Hara Yukihiko (Shizuoka JPX). Process for the production of tea catechins. USP1986094613672.
  33. Harm M. Deckers CA; Gijs van Rooijen CA; Joseph Boothe CA; Janis Goll CA; Maurice M. Moloney CA. Products for topical applications comprising oil bodies. USP2002046372234.
  34. Hara Yukihiko (Fujieda JPX) Honda Miwa (Fujieda JPX). Reducing tyrosinase activity. USP1997095670154.
  35. Theodore Hersh ; Michael A. Warshaw. Reparatives for ultraviolet radiation skin damage. USP2002016337320.
  36. Shimamura Tadakatsu (4-4 ; Nishihara 1-chome Shibuya-ku ; Tokyo JPX). Therapeutic agent for tinea. USP1992085135957.
  37. Thormar, Halldor; Kristmundsdottir, Thordis. Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections. USP2003076596763.
  38. Uwe Schonrock DE; Heiner Max DE. Use of a content of catechins or a content of green tea extract in cosmetic preparations for tanning the skin. USP2002066399046.